Ly-m19: The Lyb-2 region of mouse chromosome 4 controls a new surface alloantigen |
| |
Authors: | Nobuhiko Tada Shoji Kimura Yen Liu Benjamin A. Taylor Ulrich Hämmerling |
| |
Affiliation: | (1) Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, 10021 New York, New York;(2) The Jackson Laboratory, 04609 Bar Harbor, Maine |
| |
Abstract: | Spleen cells from an SJL mouse immunized with 70'/3 cells, an established pre-B cell line, were fused with cells of the nonsecretor myeloma line NS.1. One established hybridoma cell line (clone K10.6) continuously secreted antibody that recognized a new antigenic specificity tentatively named Ly-m19. This newly found antigen is detectable on both T and B cells. Cytotoxicity assays reveal that 75 percent of the spleen and lymph-node cells, 35 percent of bone-marrow cells, and 15 percent of thymus cells reacted with antibody of clone K10.6. Strains expressing the specificity Ly-m19.1 are characterized by negative reactions and include the strains AKR, CE/J, RF/J, GR/A, SJL, P/J, BDP/J, and LG/J. All other strains so far tested are Ly-m19.2. This strain distribution pattern distinguishes Ly-m19 from any known murine lymphocyte alloantigen, but it parallels the Lyb-2c haplotype. Linkage test of a set of AKXL recombinant inbred strains revealed close linkage of Ly-m19 and Lyb-2 loci on mouse chromosome 4.Abbreviations used in this paper LPS lipopolysaccharide - B6 C57BL/6 - Con-A concanavalin A - MLC mixed-lymphocyte cultureThe prefix m (monoclonal) is used following a suggestion by Klein and co-workers (1979). |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|